Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial

Shernan G Holtan, Preston D Steen, Nathan R Foster, Charles Erlichman, Fabiola Medeiros, Matthew M Ames, Stephanie L Safgren, David L Graham, Robert J Behrens and Matthew P Goetz

PLOS ONE, 2012, vol. 7, issue 7, 1-9

Abstract: Trial Registration: ClinicalTrials.gov NCT00066781

Date: 2012
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0039285 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 39285&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0039285

DOI: 10.1371/journal.pone.0039285

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().